Dolutegravir-based antiretroviral therapy does not reduce plasma levonorgestrel or medroxyprogesterone acetate concentrations among contraceptive users living with HIV compared with HIV-negative controls

被引：0
|
作者：
Ryan, Rebecca [1 ]
Mussa, Aamirah [1 ]
Bame, Bame [1 ]
Bapabi, Mbapi [1 ]
Moshashane, Neo [1 ]
Mechie, Imogen [1 ]
Ensor, Samuel [1 ]
Ndlovu, Neo [1 ]
Chakona, Shelby [1 ]
Simon, Selebaleng [1 ]
Tsuaneng, Maipelo [1 ]
Else, Laura [2 ]
Amara, Alieu [2 ]
Tatipamula, Vinay [2 ]
Dickinson, Laura [2 ]
Khoo, Saye [2 ]
Morroni, Chelsea [3 ]
机构：
[1] Botswana Harvard Hlth Partnership, Botswana Sexual & Reprod Hlth Initiat, Gaborone, Botswana
[2] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool, Merseyside, England
[3] Univ Edinburgh, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2024年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P196
引用
收藏
页码：187 / 187
页数：1
相关论文
共 43 条
  • [31] Treatment Outcomes of Dolutegravir- Versus Efavirenz-Based Highly Active Antiretroviral Therapy Regimens Among Treatment-Naive People Living With HIV
    Mahale, Prarthana R.
    Patel, Brijalkumar S.
    Kasmani, Navsin
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (06)
  • [32] Non-HIV Comorbid Conditions and Polypharmacy Among People Living with HIV Age 65 or Older Compared with HIV-Negative Individuals Age 65 or Older in the United States: A Retrospective Claims-Based Analysis
    Kong, Amanda M.
    Pozen, Alexis
    Anastos, Kathryn
    Kelvin, Elizabeth A.
    Nash, Denis
    AIDS PATIENT CARE AND STDS, 2019, 33 (03) : 93 - 103
  • [33] Effect of dolutegravir-based first-line antiretroviral therapy on weight and body mass index among adult people living with HIV on follow up at health facilities in Hawassa city administration, Southern Ethiopia: a retrospective cohort study
    Hirigo, Agete Tadewos
    Yilma, Daniel
    Astatkie, Ayalew
    Debebe, Zelalem
    ANNALS OF MEDICINE, 2023, 55 (02)
  • [34] EFAVIRENZ-BUT NOT NEVIRAPINE-BASED ANTIRETROVIRAL THERAPY SIGNIFICANTLY REDUCES ETONOGESTREL CONCENTRATIONS AMONG HIV-POSITIVE WOMEN USING SUBDERMAL CONTRACEPTIVE IMPLANTS
    Chappell, C.
    Lamorde, M.
    Nakalema, S.
    Chen, B.
    Riddler, S.
    Cohn, S.
    Darin, K.
    Achilles, S.
    Scarsi, K.
    CONTRACEPTION, 2016, 94 (04) : 390 - 390
  • [35] Variability of efavirenz plasma concentrations among pediatric HIV patients treated with efavirenz based combination antiretroviral therapy in Dar es Salaam, Tanzania
    Selemani Saidi Sungi
    Eliford Ngaimisi
    Nzovu Ulenga
    Philip Sasi
    Sabina Mugusi
    BMC Pharmacology and Toxicology, 19
  • [36] Variability of efavirenz plasma concentrations among pediatric HIV patients treated with efavirenz based combination antiretroviral therapy in Dar es Salaam, Tanzania
    Sungi, Selemani Saidi
    Ngaimisi, Eliford
    Ulenga, Nzovu
    Sasi, Philip
    Mugusi, Sabina
    BMC PHARMACOLOGY & TOXICOLOGY, 2018, 19
  • [37] Pretreatment HIV Drug Resistance Among Adults Initiating or Re-Initiating First-Line Antiretroviral Therapy in Zimbabwe: Fast-Tracking the Transition to Dolutegravir-Based First-Line Regimens?
    Kouamou, Vinie
    Mavetera, Justice
    Manasa, Justen
    Ndhlovu, Chiratidzo Ellen
    Katzenstein, David
    McGregor, Alan Michael
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2021, 37 (10) : 776 - 783
  • [38] Low-level viraemia and virologic failure among people living with HIV who received maintenance therapy with co-formulated bictegravir, emtricitabine and tenofovir alafenamide versus dolutegravir-based regimens
    Chen, Guan-Jhou
    Sun, Hsin-Yun
    Chen, Ling-Ya
    Hsieh, Szu-Min
    Sheng, Wang-Hui
    Liu, Wang-Da
    Chuang, Yu-Chung
    Huang, Yu-Shan
    Lin, Kuan-Yin
    Wu, Pei-Ying
    Chang, Hsi-Yen
    Luo, Yu-Zhen
    Su, Yi-Ching
    Liu, Wen-Chun
    Chang, Sui-Fang
    Chang, Sui-Yuan
    Hung, Chien-Ching
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2022, 60 (03)
  • [39] Atherogenic Index of Plasma and High-Sensitivity C-Reactive Protein Levels Among People Living With HIV on Dolutegravir and Ritonavir-Boosted Atazanavir-Based Antiretroviral Therapy and Their Correlations to CD4 Cell Counts
    Waritu, Nuredin Chura
    Usure, Rashed Edris
    Adema, Bulcha Guye
    Wakeyo, Mamud Umer
    Jemal, Mohammed
    AIDS RESEARCH AND TREATMENT, 2025, 2025 (01)
  • [40] Erratum for Banda et al., "Impact of Dolutegravir-Based Antiretroviral Therapy on Piperaquine Exposure following Dihydroartemisinin-Piperaquine Intermittent Preventive Treatment of Malaria in Pregnant Women Living with HIV" (vol 66, e00584-22, 2022)
    Banda, Clifford G.
    Nkosi, Dumisile
    Allen, Elizabeth
    Workman, Lesley
    Madanitsa, Mwayiwawo
    Chirwa, Marumbo
    Kapulula, Mayamiko
    Muyaya, Sharon
    Munharo, Steven
    Tarning, Joel
    Phiri, Kamija S.
    Mwapasa, Victor
    ter Kuile, Feiko O.
    Maartens, Gary
    Barnes, Karen I.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (01)
12345